Etoflam 60. 90. 120 60 mg. 90 mg. 120mg FC tablets.

Etoflam 60. 90. 120 60 mg. 90 mg. 120mg FC tablets.

S3
PDF Leaflet Revision Date: 11 December 2021


Clinical Summary

Quick overview from the medicine insert

Indication

Symptomatic relief of rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis, acute pain, primary dysmenorrhoea, and post-operative dental pain.

Dosage (summary)

90 mg once daily for RA and AS; 120 mg once daily for acute gout; 120 mg once daily for dysmenorrhoea; 90 mg once daily for dental pain.

Special Populations

  • Elderly
  • Hepatic impairment
  • Renal impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation; may affect fetal development.

Key Drug Interactions

  • Warfarin
  • Lithium
  • Digoxin
  • Diuretics
  • ACE inhibitors

Contraindications

  • Hypersensitivity to etoricoxib
  • Active peptic ulceration
  • Severe hepatic insufficiency
  • Severe renal impairment
  • Uncontrolled hypertension

Common side effects

  • Hypertension
  • Dizziness
  • Gastrointestinal disorders
  • Oedema
  • Palpitations

Counselling Points

  • Monitor blood pressure
  • Avoid in pregnancy
  • Report any skin reactions
  • Use the lowest effective dose for the shortest duration

Serious warnings

  • Cardiovascular events
  • Gastrointestinal complications
  • Serious skin reactions
  • Renal injury

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Etoflam 60. 90. 120 60 mg. 90 mg. 120mg FC tablets.
1/-

Connecting to Document Server

Decrypting and optimizing pharmaceutical leaflet...

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW